United-Guardian, Inc. (UG)

US — Consumer Defensive Sector

Peers: UTMD UNB PMD UBOH UNTY

Automate Your Wheel Strategy on UG

With Tiblio's Option Bot, you can configure your own wheel strategy including UG - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

symbol UG
Rev/Share 2.4831
Book/Share 0.0027
PB 0.0
Debt/Equity 0.0
CurrentRatio 0.0
ROIC 206.8751

MktCap 38132856.0
FreeCF/Share 0.5949
PFCF 13.9523
PE 13.2115
Debt/Assets 0.0
DivYield 0.0843
ROE 0.3263

Rating B-
Score 3
Recommendation Neutral
P/E Score 3
DCF Score 4
P/B Score 1
D/E Score 1

Recent Analyst Ratings

Type	Ticker	Analyst Firm	Previous Rating	Current Rating	Previous Price Target	Current Price Target	Date
No ratings available.

News

United-Guardian Q1 Earnings Fall 39% Y/Y as Cosmetic Sales Tumble 63%

UG
Published: May 15, 2025 by: Zacks Investment Research
Sentiment: Negative

UG's Q1 earnings drop 39% as cosmetic sales plunge, offsetting gains in pharmaceuticals and medical lubricants.

image for news United-Guardian Q1 Earnings Fall 39% Y/Y as Cosmetic Sales Tumble 63%

United-Guardian Stock Dips 9.6% Despite Robust 2024 Sales & Earnings

UG
Published: March 26, 2025 by: Zacks Investment Research
Sentiment: Negative

UG's 2024 sales grow 12% y/y and earnings rise. Yet. the stock falls amid supply challenges and muted guidance, sparking mixed investor sentiment.

image for news United-Guardian Stock Dips 9.6% Despite Robust 2024 Sales & Earnings

United-Guardian Reports 2024 Financial Results

UG
Published: March 21, 2025 by: GlobeNewsWire
Sentiment: Neutral

HAUPPAUGE, N.Y., March 21, 2025 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) reported that net sales and net income for FY 2024 increased compared to FY 2023. Net sales for the year increased by 12% from $10,885,154 in 2023 to $12,181,971 in 2024, generating net income of $3,250,875 ($0.71 per share) in 2024 compared to $2,581,370 ($0.56 per share) in 2023.

image for news United-Guardian Reports 2024 Financial Results

About United-Guardian, Inc. (UG)

IPO Date 1980-03-17
Website https://www.u-g.com
Industry Household & Personal Products
CEO Donna Vigilante
Employees 24

United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL NATURAL consisting of natural ingredients for cosmetic use; LUBRAJEL MARINE; LUBRASIL II SB, a special formulation of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base; LUBRAJEL II XD; B-122, a powdered lubricant that is used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; KLENSOFT, a surfactant, which is used in shampoos, shower gels, makeup removers, and other cosmetic formulations; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC and LUBRAJEL FA that are LUBRAJEL formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder, and localized infections in the peritoneum, as well as eye, ear, nose and throat, and sinuses. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and development primarily related to the development of cosmetic ingredients. It markets its products through marketing partners, distributors, and wholesalers. The company was founded in 1942 and is based in Hauppauge, New York.